Private company

AGILE THERAPEUTICS INC

Last updated Oct 18, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address500 College Road East, Suite 310, Princeton, Nj 08540-66352
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

54.2%Gross margin3
-101.5%Operating margin3
-73.8%Net margin3
80.0%Revenue growth, 20233

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue46¢$9.0M
  • Research and development11¢$2.2M
  • Other costs36¢$7.0M
  • Interest7¢$1.4M

Out of $19.6M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$19.6M in 2023
0$5.0M$10.0M$15.0M$20.0M2017: $0$020172018: $0$020182019: $0$020192020: $749.0K$749.0K20202021: $4.1M$4.1M2021+448%2022: $10.9M$10.9M2022+165%2023: $19.6M$19.6M2023+80%
Gross profit73$10.6M in 2023+2173% since 2020
-$10.0M-$5.0M0$5.0M$10.0M$15.0M2020: $467.0K$467.0K20202021: -$6.6M-$6.6M20212022: $4.0M$4.0M20222023: $10.6M$10.6M2023+162%
Operating income68973-$19.9M in 2023−26% since 2017
-$80.0M-$60.0M-$40.0M-$20.0M02017: -$26.8M-$26.8M20172018: -$19.5M-$19.5M2018−27%2019: -$18.9M-$18.9M2019−3%2020: -$49.1M-$49.1M2020+160%2021: -$71.0M-$71.0M2021+45%2022: -$52.6M-$52.6M2022−26%2023: -$19.9M-$19.9M2023−62%
Net income68973-$14.5M in 2023−49% since 2017
-$80.0M-$60.0M-$40.0M-$20.0M02017: -$28.3M-$28.3M20172018: -$19.8M-$19.8M2018−30%2019: -$18.6M-$18.6M2019−6%2020: -$51.9M-$51.9M2020+179%2021: -$71.1M-$71.1M2021+37%2022: -$25.4M-$25.4M2022−64%2023: -$14.5M-$14.5M2023−43%
Fiscal year2017201820192020202120222023
Revenue$04$05$06$749.0K7$4.1M3$10.9M3$19.6M3
Cost of revenue$282.0K7$10.7M3$6.8M3$9.0M3
Gross profit$467.0K7-$6.6M3$4.0M3$10.6M3
Research and development$14.4M6$9.8M8$9.9M9$13.5M7$6.2M3$3.3M3$2.2M3
Operating income-$26.8M6-$19.5M8-$18.9M9-$49.1M7-$71.0M3-$52.6M3-$19.9M3
Interest$1.9M6$1.1M8$3.1M7$3.9M3$3.1M3$1.4M3
Income tax-$477.0K8-$4.7M3
Net income-$28.3M6-$19.8M8-$18.6M9-$51.9M7-$71.1M3-$25.4M3-$14.5M3
Earnings per share-$0.389-$24.407-$1,464.203-$58.793-$6.713
Earnings per share (diluted)-$0.389-$24.407-$1,464.203-$58.793-$6.713

Compare AGILE THERAPEUTICS INC with another company

Recent filings

  1. Aug 26, 20248-K
  2. Aug 26, 20244 OWNERSHIP DOCUMENT
  3. Aug 26, 20244 OWNERSHIP DOCUMENT
  4. Aug 26, 20244 OWNERSHIP DOCUMENT
  5. Aug 26, 20244 OWNERSHIP DOCUMENT
  6. Aug 26, 20244 OWNERSHIP DOCUMENT
  7. Aug 26, 20244 OWNERSHIP DOCUMENT
  8. Aug 26, 20244 OWNERSHIP DOCUMENT
  9. Aug 26, 20244 OWNERSHIP DOCUMENT
  10. Aug 26, 20244 OWNERSHIP DOCUMENT
  11. Aug 26, 20244 OWNERSHIP DOCUMENT
  12. Aug 26, 20244 OWNERSHIP DOCUMENT
  13. Aug 12, 202410-Q
  14. Jul 16, 20248-K/A
  15. Jul 15, 20248-K/A

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11